120 related articles for article (PubMed ID: 24318956)
1. Is digoxin use for cardiovascular disease associated with risk of prostate cancer?
Wright JL; Hansten PD; Stanford JL
Prostate; 2014 Jan; 74(1):97-102. PubMed ID: 24318956
[TBL] [Abstract][Full Text] [Related]
2. Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study.
Wright JL; Stanford JL
Cancer Causes Control; 2009 Nov; 20(9):1617-22. PubMed ID: 19653109
[TBL] [Abstract][Full Text] [Related]
3. Digoxin lowers the incidence of prostate cancer: A nationwide population-based study.
Lin TP; Fan YH; Chen YC; Huang WJS
J Chin Med Assoc; 2020 Apr; 83(4):377-381. PubMed ID: 32132383
[TBL] [Abstract][Full Text] [Related]
4. Male pattern baldness and prostate cancer risk in a population-based case-control study.
Wright JL; Page ST; Lin DW; Stanford JL
Cancer Epidemiol; 2010 Apr; 34(2):131-5. PubMed ID: 20206591
[TBL] [Abstract][Full Text] [Related]
5. Digoxin reduces the incidence of prostate cancer but increases the cancer-specific mortality: A systematic review and pooled analysis.
Zhao S; Li X; Wu W; Liu S; Shen M; Zhang Z; He J
Andrologia; 2021 Dec; 53(11):e14217. PubMed ID: 34414594
[TBL] [Abstract][Full Text] [Related]
6. A cohort study of digoxin exposure and mortality in men with prostate cancer.
Flahavan EM; Sharp L; Bennett K; Barron TI
BJU Int; 2014 Feb; 113(2):236-45. PubMed ID: 23937513
[TBL] [Abstract][Full Text] [Related]
7. Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study.
Ahern TP; Lash TL; Sørensen HT; Pedersen L
Breast Cancer Res; 2008; 10(6):R102. PubMed ID: 19055760
[TBL] [Abstract][Full Text] [Related]
8. Prostatitis, other genitourinary infections and prostate cancer: results from a population-based case-control study.
Boehm K; Valdivieso R; Meskawi M; Larcher A; Schiffmann J; Sun M; Graefen M; Saad F; Parent MÉ; Karakiewicz PI
World J Urol; 2016 Mar; 34(3):425-30. PubMed ID: 26108732
[TBL] [Abstract][Full Text] [Related]
9. Sotalol, but not digoxin is associated with decreased prostate cancer risk: A population-based case-control study.
Kaapu KJ; Ahti J; Tammela TL; Auvinen A; Murtola TJ
Int J Cancer; 2015 Sep; 137(5):1187-95. PubMed ID: 25656312
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial.
Kaapu KJ; Murtola TJ; Määttänen L; Talala K; Taari K; Tammela TL; Auvinen A
Cancer Causes Control; 2016 Feb; 27(2):157-64. PubMed ID: 26573846
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus and prostate cancer risk.
Pierce BL; Plymate S; Ostrander EA; Stanford JL
Prostate; 2008 Jul; 68(10):1126-32. PubMed ID: 18459104
[TBL] [Abstract][Full Text] [Related]
12. Calcium Channel Blocker Use and Risk of Prostate Cancer by TMPRSS2:ERG Gene Fusion Status.
Geybels MS; McCloskey KD; Mills IG; Stanford JL
Prostate; 2017 Feb; 77(3):282-290. PubMed ID: 27753122
[TBL] [Abstract][Full Text] [Related]
13. Obesity and the risk of prostate cancer.
Porter MP; Stanford JL
Prostate; 2005 Mar; 62(4):316-21. PubMed ID: 15389806
[TBL] [Abstract][Full Text] [Related]
14. Metformin use and prostate cancer risk.
Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
[TBL] [Abstract][Full Text] [Related]
15. Multiple events of fractures and cardiovascular and thromboembolic disease following prostate cancer diagnosis: results from the population-based PCBaSe Sweden.
Van Hemelrijck M; Garmo H; Holmberg L; Stattin P; Adolfsson J
Eur Urol; 2012 Apr; 61(4):690-700. PubMed ID: 21945719
[TBL] [Abstract][Full Text] [Related]
16. Digoxin use may increase the relative risk of acute pancreatitis: A population-based case-control study in Taiwan.
Lai SW; Lin CL; Liao KF
Int J Cardiol; 2015 Feb; 181():235-8. PubMed ID: 25528527
[TBL] [Abstract][Full Text] [Related]
17. BPH: a tell-tale sign of prostate cancer? Results from the Prostate Cancer and Environment Study (PROtEuS).
Boehm K; Valdivieso R; Meskawi M; Larcher A; Sun M; Sosa J; Blanc-Lapierre A; Weiss D; Graefen M; Saad F; Parent MÉ; Karakiewicz PI
World J Urol; 2015 Dec; 33(12):2063-9. PubMed ID: 25824539
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer risk in men with prostate and breast cancer family history: results from the REDUCE study (R1).
Thomas JA; Gerber L; Moreira DM; Hamilton RJ; Bañez LL; Castro-Santamaria R; Andriole GL; Isaacs WB; Xu J; Freedland SJ
J Intern Med; 2012 Jul; 272(1):85-92. PubMed ID: 22211699
[TBL] [Abstract][Full Text] [Related]
19. The risk of prostate cancer for men on aspirin, statin or antidiabetic medications.
Nordström T; Clements M; Karlsson R; Adolfsson J; Grönberg H
Eur J Cancer; 2015 Apr; 51(6):725-33. PubMed ID: 25727881
[TBL] [Abstract][Full Text] [Related]
20. Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology.
Campi R; Brookman-May SD; Subiela Henríquez JD; Akdoğan B; Brausi M; Klatte T; Langenhuijsen JF; Linares-Espinos E; Marszalek M; Roupret M; Stief CG; Volpe A; Minervini A; Rodriguez-Faba O
Eur Urol Focus; 2019 Nov; 5(6):1029-1057. PubMed ID: 29661588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
